Telmisartan Market, by Strength (20mg, 40mg, and 80mg), by Indication (Hypertension, Cardiac Arrest, and Stroke), by Composition (Single and Combinational), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : Mar 2019 |
  • Pages : 157 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Telmisartan Market Insights

Availability of better treatment options for hypertension has lead substantial portion of the hypertensive population with controlled blood pressure. But rising population with cardiovascular, and associated disorders urges need for different antihypertensive drugs in the global market. Telmisartan is a non-peptide angiotensin receptor blocker intended for treatment of hypertension and other cardiovascular disorders. Telmisartan was approved by the US Food and Drug Administration (USFDA) in 1998, for the treatment of hypertension alone or in combination with other compounds.

The global telmisartan market size was valued at US$ 3,880.9 million in 2017, and is expected to witness a CAGR of 1.4% over the forecast period (2018 – 2026).

Figure 1. Global Telmisartan Market Value (US$ Mn) Analysis and Forecast and Absolute $ Opportunity

Telmisartan  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

Increasing number of government initiatives for creating awareness regarding cardiovascular and blood pressure disorders is expected to drive growth of the Telmisartan market

The Texas Council on cardiovascular disease and stroke works with key players to implement plan for reducing rate of cardiovascular disease and stroke burden in Texas. The plan provides an overview of the current state of cardiovascular disease and stroke in Texas, summary of findings from the heart disease and stroke prevention system assessment, as well as information on mortality, morbidity, prevalence, and related risk factors.  

Rising prevalence of hypertension globally is creating disease burden and propelling demand for developing antihypertensive drugs in the global market. For instance, the National Health and Nutrition Examination Surveys (NHANES) provided important epidemiologic information on the prevalence and control of hypertension in the U.S., between 1960 and 2014, which stated that 26 percent of the world's adult population (972 million) was suffering from hypertension in 2000, while number increased by 31 percent (1.39 billion) in 2010, and the number is estimated to reach 1.56 billion by 2025.

Furthermore, increasing marketing approvals for generic versions of telmisartan is expected to propel growth of telmisartan market. For instance, in August 2017, Zydus Cadila received approval from the US FDA to market telmisartan and hydrochlorothiazide tablets, in the strengths of 40mg/ 12.5 mg, 80 mg/12.5 mg and 80mg/25 mg.

However, drug shortages are likely to inhibit the growth of the Telmisartan market. For instance in June 2018, US FDA reported shortage of Boehringer Ingelheim Pharmaceuticals, Inc.’s, telmisartan and amlodipine (Twynsta) tablets 80mg/10mg, 30 count blister, due to discontinuation of its business. Moreover, Drug Shortages Canada also reported shortage of Teva- Telmisartan 80mg tablet in Canada, due to lack of complying with good manufacturing practices.

Telmisartan Market- Regional Analysis

Regional segmentation of the global Telmisartan market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America hold the major share in global telmisartan market due to product launches in U.S. For instance, in July 2014, Mylan Inc., a global pharmaceutical company launched telmisartan tablets USP, 20 mg, 40 mg ,and 80 mg, which are the generic version of Boehringer Ingelheim’s Micardis tablets that received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA).

Asia Pacific is expected to witness fastest growth in the global Telmisartan market due to increasing awareness among population regarding hypertension and related cardiovascular disorders. For instance, since 2005, World Hypertension Day is celebrated in Australia in the Month of May to support stakeholders such as Hypertension Societies, patient interest groups, and pharmaceutical industries.

Figure 2: Global Telmisartan Market Value (US$ Mn), By Region

Telmisartan  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

Telmisartan Market- Competitive Landscape

Key players operating in the Telmisartan market include Medtronic Plc., General Electric Company, C. R. Bard, Inc., ConvaTec Group plc. Smith Medical, Inc., KindWell Medical Equipment Co.,Ltd, Royax, Fuji Systems Corp., Teleflex Incorporated., Neurovision Medical Products, and Intersurgical GmbH

Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for therapy of hypertension, in cardiac arrest, and in stroke management. Telmisartan was approved for use in the U.S., for treatment of hypertension in 1998. Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis.  The typical dose of Telmisartan in adults is 40 to 80 mg once daily, and it is used long term.  Telmisartan is also available in fixed combinations with hydrochlorothiazide, and amlodipine.

Market Dynamics

Prevalence of high blood pressures, is increasing globally attributed to rising geriatric population, chronic disorders such as diabetes, and changing lifestyles which in turn is expected to increase the demand for telmisartan in global market. According to Blood Pressure UK, 2017 update, high blood pressure is the leading cause of heart disease and stroke, killing around 7.5 million people worldwide every year.  In 1975, 594 million people were suffering from high blood pressure which increased to 1.1 billion in 2015 and is thought to be due to population growth and an aging population. Thus, rise in geriatric population suffering from high blood pressure is expected to be major factor for growth of telmisartan market in the forecast period.

Furthermore, increasing approvals for Abbreviated new Drug Application (ANDA) for manufacturing of generic telmisartan tablets is propelling growth of telmisartan in the global market. For instance, in July 2014, Glenmark Generics Inc., USA—a subsidiary of Glenmark Generics Limited—received ANDA approval from the U.S. Food and Drug Administration (USFDA) for telmisartan tablets.

Key features of the study:

  • This report provides in-depth analysis of the telmisartan market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global telmisartan market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include C.H. Boehringer Sohn AG & Ko. KG, Glenmark Generics Inc., Torrent Pharmaceuticals Ltd., Solco Healthcare U.S., Mylan Inc., Aurobindo Pharma Limited, Yichang Changjiang Pharmaceutical Co., Ltd, Wanbang Biopharmaceuticals, and Nippon Boehringer Ingelheim Co., Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global telmisartan market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for telmisartan market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Telmisartan Market, By Strength:
    • 20mg
    • 40mg
    • 80mg
  • Global Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
  • Global Telmisartan Market, By Composition:
    • Single
    • Combinational
  • Global Telmisartan Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Telmisartan Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Africa
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
  • Company Profiles
    • C.H. Boehringer Sohn AG & Ko. KG *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Glenmark Generics Inc.
    • Torrent Pharmaceuticals Ltd.
    • Solco Healthcare U.S.
    • Aurobindo Pharma Limited
    • Mylan Inc.
    • Yichang Changjiang Pharmaceutical Co., Ltd
    • Wanbang Biopharmaceuticals.
    • Nippon Boehringer Ingelheim Co., Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Strength
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Pipeline Analysis
    • Epidemiology
    • Historical Overview
    • Merger and Acquisition
    • Regulatory Scenario
    • PORTER’S Five Forces
    • PEST Analysis
  4. Global Telmisartan Market, By Strength, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • 20mg
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • 40mg
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • 80mg
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Telmisartan Market, By Indication, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hypertension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Cardiac Arrest
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Stroke
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Telmisartan Market, By Composition, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Single
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Combinational
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Telmisartan Market, By Distribution Channel, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  8. Global Telmisartan Market, By Regions, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2016 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • C.H. Boehringer Sohn AG & Ko. KG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Glenmark Generics Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Torrent Pharmaceuticals Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Solco Healthcare U.S.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Mylan Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Aurobindo Pharma Limited
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Yichang Changjiang Pharmaceutical Co., Ltd
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Wanbang Biopharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Nippon Boehringer Ingelheim Co., Ltd.
        • Company Overview.   
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 23 market data tables and 19 figures on "Telmisartan Market” - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.